Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ADRO

Aduro Biotech (ADRO) Stock Price, News & Analysis

Aduro Biotech logo

About Aduro Biotech Stock (NASDAQ:ADRO)

Key Stats

Today's Range
N/A
50-Day Range
$2.28
$14.60
52-Week Range
N/A
Volume
171,500 shs
Average Volume
162,237 shs
Market Capitalization
$236.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aduro Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ADRO Stock News Headlines

Aduro Clean Technologies Inc.
Trump to get REVENGE on the banks??
Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network — and one $3 asset, with nine ETFs already in the works, may skyrocket if his plan moves forward.tc pixel
ACTHD Aduro Clean Technologies Inc.
Aduro Clean Technologies Inc Ordinary Shares
PT Adaro Energy Indonesia Tbk
PT Adaro Energy Indonesia Tbk ADRO
See More Headlines

ADRO Stock Analysis - Frequently Asked Questions

Aduro Biotech, Inc. (NASDAQ:ADRO) released its quarterly earnings data on Monday, May, 4th. The biotechnology company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by $0.05. The biotechnology company had revenue of $13.95 million for the quarter, compared to analysts' expectations of $8.81 million. Aduro Biotech had a negative net margin of 230.92% and a negative trailing twelve-month return on equity of 101.73%.

Aduro Biotech (ADRO) raised $119 million in an IPO on Wednesday, April 15th 2015. The company issued 7,000,000 shares at $17.00 per share. BofA Merrill Lynch and Leerink Partners served as the underwriters for the IPO and William Blair and Canaccord Genuity were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aduro Biotech investors own include Regulus Therapeutics (RGLS), Exact Sciences (EXAS), Flexion Therapeutics (FLXN), Paratek Pharmaceuticals (PRTK), Anavex Life Sciences (AVXL), VBI Vaccines (VBIV) and Amarin (AMRN).

Company Calendar

Last Earnings
5/04/2020
Today
10/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ADRO
CIK
1435049
Fax
N/A
Employees
152
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.37 million
Net Margins
-230.92%
Pretax Margin
N/A
Return on Equity
-101.73%
Return on Assets
-22.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.91
Quick Ratio
8.91

Sales & Book Value

Annual Sales
$17.26 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
16,212,000
Free Float
N/A
Market Cap
$236.61 million
Optionable
Optionable
Beta
0.40
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:ADRO) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners